Castle Biosciences (CSTL) EPS (Basic) (2018 - 2025)
Historic EPS (Basic) for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$0.02.
- Castle Biosciences' EPS (Basic) fell 12500.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.41, marking a year-over-year decrease of 28636.36%. This contributed to the annual value of $0.66 for FY2024, which is 13069.45% up from last year.
- According to the latest figures from Q3 2025, Castle Biosciences' EPS (Basic) is -$0.02, which was down 12500.0% from $0.16 recorded in Q2 2025.
- In the past 5 years, Castle Biosciences' EPS (Basic) registered a high of $0.35 during Q4 2024, and its lowest value of -$1.1 during Q1 2023.
- In the last 5 years, Castle Biosciences' EPS (Basic) had a median value of -$0.25 in 2021 and averaged -$0.32.
- Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 106666.67% in 2023, then surged by 48362.46% in 2024.
- Over the past 5 years, Castle Biosciences' EPS (Basic) (Quarter) stood at -$0.25 in 2021, then crashed by 216.0% to -$0.79 in 2022, then skyrocketed by 88.61% to -$0.09 in 2023, then skyrocketed by 483.62% to $0.35 in 2024, then plummeted by 105.79% to -$0.02 in 2025.
- Its last three reported values are -$0.02 in Q3 2025, $0.16 for Q2 2025, and -$0.9 during Q1 2025.